Rapamycin inhibits the growth of glioblastoma

[1]  B. Kasiske,et al.  A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation , 2012, Journal of transplantation.

[2]  W. Weimar,et al.  Cross-Border Quest: The Reality and Legality of Transplant Tourism , 2012, Journal of transplantation.

[3]  William A Weiss,et al.  Inhibition of PI3K-Akt-mTOR signaling in glioblastoma by mTORC1/2 inhibitors. , 2012, Methods in molecular biology.

[4]  Wenzhuo Zhuang,et al.  Induction of autophagy promotes differentiation of glioma‐initiating cells and their radiosensitivity , 2011, International journal of cancer.

[5]  M. Junier,et al.  Secreted factors from brain endothelial cells maintain glioblastoma stem‐like cell expansion through the mTOR pathway , 2011, EMBO reports.

[6]  P. Gean,et al.  Minocycline inhibits the growth of glioma by inducing autophagy , 2011, Autophagy.

[7]  Alfeu Zanotto-Filho,et al.  NFκB inhibitors induce cell death in glioblastomas. , 2011, Biochemical pharmacology.

[8]  D. Häussinger,et al.  Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells , 2010, Molecular Cancer Therapeutics.

[9]  G. Vassal,et al.  Mechanistic Evaluation of the Novel HSP90 Inhibitor NVP-AUY922 in Adult and Pediatric Glioblastoma , 2010, Molecular Cancer Therapeutics.

[10]  Shilpa Puli,et al.  Effect of Combination Treatment of Rapamycin and Isoflavones on mTOR Pathway in Human Glioblastoma (U87) Cells , 2010, Neurochemical Research.

[11]  Zhenghong Qin,et al.  Autophagy impairment inhibits differentiation of glioma stem/progenitor cells , 2010, Brain Research.

[12]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[13]  Zhenghong Qin,et al.  The role of autophagy in sensitizing malignant glioma cells to radiation therapy. , 2009, Acta biochimica et biophysica Sinica.

[14]  J. Fueyo,et al.  Autophagy pathways in glioblastoma. , 2009, Methods in enzymology.

[15]  Laurentiu M. Pop,et al.  Targeting mammalian target of rapamycin to both downregulate and disable the P-glycoprotein pump in multidrug-resistant B-cell lymphoma cell lines , 2009, Leukemia & lymphoma.

[16]  Tianhong Pan,et al.  Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement , 2008, Neurobiology of Disease.

[17]  S. Horvath,et al.  Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma , 2008, PLoS medicine.

[18]  R. Kiss,et al.  Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. , 2007, The oncologist.

[19]  M. Mehta,et al.  Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme. , 2007, Clinical advances in hematology & oncology : H&O.

[20]  R. Kiss,et al.  Autophagy, the Trojan horse to combat glioblastomas. , 2006, Neurosurgical focus.

[21]  M. Berger,et al.  mTOR Controls FLIPS Translation and TRAIL Sensitivity in Glioblastoma Multiforme Cells , 2005, Molecular and Cellular Biology.

[22]  P. Pandolfi,et al.  mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. , 2005, Neoplasia.

[23]  Brett L Carlson,et al.  Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy. , 2002, Cancer research.

[24]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[25]  D. Graham,et al.  Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. , 1987, Journal of neurology, neurosurgery, and psychiatry.